Related Experiment Video
Updated: Aug 17, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Age, cancer and the risk of venous thromboembolism
Filippo Luca Fimognari1, Lazzaro Repetto, Leo Moro
1University Campus Biomedico di Roma, Rome, Italy. filippo.fimognari@virgilio.it
Abstract:
Cancer increases the risk for venous thromboembolism (VTE) and patients presenting with a seemingly idiopathic VTE often have an occult cancer. Aging also is a risk factor for VTE. Therefore, old patients with cancer are supposed to be at very high risk for VTE, but inherent data are sporadic and contrasting. We reviewed the literature about the relation between cancer and VTE, with particular attention to findings concerning elderly patients. While aging and postmenopausal status enhance the risk of chemotherapy-induced VTE in women with breast cancer, the rate of a cancer diagnosis in the first year after VTE seems to be even lower in elderly compared to young subjects. Thus, further studies are needed to understand whether or not aging and cancer have additive thrombogenic effects. Finally, we discuss prophylactic and therapeutic strategies.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction